subgroup of
arthritis)
→
ReceivesAction
→
treated with infliximab
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| compared to biologics-naïve patients | 3 | other |
| rheumatoid arthritis → be treated with → infliximab | 3 |
| negative | neutral | positive |
| 0.295 | 0.659 | 0.046 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 11.343 |